Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Top Story
Kickback
Utah lab owner admits role in $89M kickback scheme involving cancer genetic screening tests
According to case documents and court statements, the lab owner and others paid kickbacks and bribes to various parties in exchange for referrals and orders for cancer genetic screening tests.
Featured
Proteomics
SomaLogic CEO steps down; Q4 revenue declines 18%
Alzheimer's
Study takes aim at blood test for multiple pathways implicated in Alzheimer's disease
Latest News
Hemex Health nabs $3M NIH grant to develop portable test for sickle cell disease
March 29, 2023
Simple blood test can detect PTSD biomarkers
March 28, 2023
Acutis Diagnostics to use Sophia Genetics technology to develop NGS test
March 28, 2023
Seegene collaborates with Hy Laboratories, seeks similar deals to broaden syndromic testing
March 28, 2023
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Sign Up
Business Insights
Non Small Cell Lung Cancer
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
Mergers & Acquisitions
Calibre Scientific acquires U.K. provider of scientific equipment, supplies, services
Business Insights
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
COVID-19
Pandemic played out in vastly different ways across the U.S.: Study
Diagnostic Technologies
Proteomics
SomaLogic CEO steps down; Q4 revenue declines 18%
Liquid Biopsy
OraSure, nRichDx to offer products for researchers developing urine-based liquid biopsy assays
Sequencing
Acutis Diagnostics to use Sophia Genetics technology to develop NGS test
Collaboration
Seegene collaborates with Hy Laboratories, seeks similar deals to broaden syndromic testing
Diseases
Psychological Disorders
Simple blood test can detect PTSD biomarkers
Immunoassays
Serum protein in study predicted which patients might die without a liver transplant
Policy and Regulation
PreludeDx obtains CMS advanced approval for DCIS test
Regulatory Approval
Biolytical Laboratories nabs Health Canada authorization for HIV-1/2 syphilis antibody test
More from LabPulse.com
OraSure, nRichDx to offer products for researchers developing urine-based liquid biopsy assays
The firms noted that their products use first-void urine, which is enriched in biomarkers suitable for molecular analysis by people researching sexually-transmitted infections, human papillomavirus, and early stage cancers.
March 27, 2023
Serum protein in study predicted which patients might die without a liver transplant
A retrospective analysis of blood samples and medical records from 270 patients hospitalized for acute liver failure analyzed serum concentrations of CPS1, a short-lived but abundant protein.
March 27, 2023
PreludeDx obtains CMS advanced approval for DCIS test
The CMS approval, effective April 1, confirms that the test meets specific criteria established for laboratory tests under the Protecting Access to Medicare Act of 2014 (PAMA).
March 28, 2023
Biolytical Laboratories nabs Health Canada authorization for HIV-1/2 syphilis antibody test
The test detects HIV-1, HIV-2, and syphilis antibodies using a sample and fingerprick, delivering results in one minute or less.
March 27, 2023
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
The AmoyDx PLC Panel has been approved in Japan for the identification of activating alterations in seven driver genes, including RET, to be used in identifying patients whose NSCLC is likely to respond to treatment with selpercatinib.
March 27, 2023
Illumina NGS software to enable tertiary analysis for oncology, rare disease
The software streamlines interpretation and reporting from a range of assay types. It enables labs to scale up the use of NGS and reduce turnaround time of clinical reporting through integration of third-party knowledge bases.
March 27, 2023
Most Popular
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Quest Diagnostics offers suite of services for transplant patients and living donors
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Serum protein in study predicted which patients might die without a liver transplant
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
More from LabPulse.com
What to do when genetic tests reveal links to cardiovascular disease: Scientific statement
Increased use of genetic testing means people may discover they have a genetic abnormality, or gene variant, associated with cardiovascular disease.
March 27, 2023
Calibre Scientific acquires U.K. provider of scientific equipment, supplies, services
According to Calibre, SciQuip offers a broad and diversified portfolio whose product lines include centrifugation, incubation, ovens, freezers, freeze drying, liquid handling, and mission-critical laboratory equipment.
March 27, 2023
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
The doctors billed Medicaid for millions of dollars in medically unnecessary urinalysis testing for their patients, including testing allegedly conducted on faulty machinery, OIG said.
March 24, 2023
Pandemic played out in vastly different ways across the U.S.: Study
A state-by-state analysis of COVID-19 impacts across the U.S. revealed the forces driving wide variations in health, education, and economic performance.
March 24, 2023
Frequent COVID-19 testing of nursing home staff saved lives: Study
Nursing homes that conducted frequent staff surveillance testing from 2020 to 2022 experienced significantly lower COVID-19 cases and deaths among residents.
March 23, 2023
Impact of circadian rhythms on cellular functions points to better ways to treat cancer
Circulating tumor cells (CTCs) were more likely to move through vessel walls during sleep, and were highly prone to metastasize. Single-cell RNA sequencing revealed the genetic upregulation responsible for the metastatic potential.
March 24, 2023
